A study on the usefulness of knerr repertory in treating psoriasis using pasi score to measure improvement

Clinical utility of knerr repertory in the treatment of psoriasis using pasi score as a prognostic tool

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/07/114039

Enrollment

Registered

2026-07-15

Start date

Unknown

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

Intervention1: Individualized Homoeopathic Drugs: Patients will receive Individualized Homoeopathic Treatment in dosage of 3 to 5 globules per day,,frequency of 3 days in a duration of 6 months Contro

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Psoraisis,Patients of all age groups of both sexes,Patients who expresses their willingness to participate in the study through signed consent form

Exclusion criteria

Exclusion criteria: The study does not involve patients who have congenital abnormalities,patients with advanced irreversible pathological conditions and women in pregnancy and lactation

Design outcomes

Primary

Measure	Time frame
clinical understanding of knerr repertoryTimepoint: 24 months	—

Secondary

Measure	Time frame
To Evaluate to clinical utility of knerr repertory in th treatment of psoriasis and assess treatment outcomes using the Pasi scoreTimepoint: 24 months	—

Countries

India

Contacts

Public ContactDr p satyaveni

Jsps government homoeopathic medical college and hospital

drsatyaveni.p@gmail.com9848387268

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026